Accepted answer
Answering this needs the units, because endotoxin units per milligram and per millilitre are different quantities and get confused constantly.
Certificates that report endotoxin do so in EU per milligram of peptide. To convert to a dose exposure, multiply by the milligrams administered — which is why a low figure per milligram can still matter at a high dose.
Dead space by syringe type
| Configuration | Dead volume | Loss at 5 mg/mL | Over 20 draws |
|---|
| Fixed-needle insulin syringe | 3–5 µL | 15–25 µg | 0.3–0.5 mg |
| Low-dead-space, detachable | <2 µL | <10 µg | <0.2 mg |
| Standard luer-lock + 30G | 35–60 µL | 175–300 µg | 3.5–6 mg |
| Luer-lock + 21G drawing needle | 70–100 µL | 350–500 µg | 7–10 mg |
Concretely, the pharmacopoeial parenteral limit is generally 5 endotoxin units per kilogram of body weight per hour for non-intrathecal routes. For a 70 kg adult that is 350 EU per hour across all parenteral products administered.
Water for injection carries a specified endotoxin limit precisely because water systems are the dominant contamination route in parenteral manufacturing.
Nothing here is medical advice, and research-use compounds are not approved for human use.
Filtration does not remove it. Autoclaving does not destroy it. Only specific processes do.
edited 23 May 2026 by micron22 — updated for the 2026 guidance change